John Landon

Title: Innovations and Contributions of Inventor John Landon

Introduction

John Landon is a notable inventor based in Newcastle Emlyn, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions and therapies. With a total of five patents to his name, Landon's work has the potential to impact medical treatments significantly.

Latest Patents

Landon's latest patents include an "Ovine derived human TNFα polyclonal antibody composition for oral administration." This invention focuses on an antibody composition that comprises intact blood-derived polyclonal antibodies binding to human tumor necrosis factor α (TNFα). It also includes methods for protecting these antibodies during gastrointestinal transit, along with manufacturing methods, kits, and therapeutic applications. Another significant patent is for "Filovirus therapy," which provides antibodies for the treatment and prevention of Filovirus diseases, particularly Ebola virus disease. This patent also includes immunogens designed to elicit such antibodies.

Career Highlights

Throughout his career, John Landon has worked with various organizations, including Micropharm Limited and the Health Protection Agency. His work in these companies has allowed him to develop innovative solutions in the field of health and medicine.

Collaborations

Landon has collaborated with notable individuals such as Clifford Charles Shone and April Roberts. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

John Landon's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches in treating serious diseases.